Printer Friendly

Articles from US Pharmaceuticals (April 29, 2019)

1-19 out of 19 article(s)
Title Author Type Words
Abbot Laboratories (NYSE: ABT). 1716
Abbvie (NYSE: ABBV) - AbbVie Expands Immunology Portfolio in the U.S. with FDA Approval of SKYRIZI[TM] (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis -- 23/4/2019. 851
Abbvie (NYSE: ABBV). 1760
AmerisourceBergen Corporation (NYSE:ABC) - US Bioservices Selected by Janssen as Single-Source Specialty Pharmacy Provider for BALVERSA[TM] (erdafitinib) -- 26/4/2019. 414
AstraZeneca (NYSE: AZN). 8379
Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals) (NYSE: BHC). 4954
Bausch Health Companies Inc. (NYSE:BHC) - Salix Enters Into Exclusive License Agreement With Mitsubishi Tanabe Pharma To Develop And Commercialize Late Stage Investigational S1P Modulator For The Treatment Of Inflammatory Bowel Disease -- 25/4/2019. 342
Baxter International (NYSE: BAX). 1668
Bristol-Myers Squibb (NYSE: BMY). 1515
Eli Lilly & Company (NYSE: LLY) - U.S. Court of Appeals Rules in Favor of Lilly in Alimta Vitamin Regimen Patent Lawsuit -- 26/4/2019. 486
GlaxoSmithKline (LSE: GSK). 17495
Johnson & Johnson (NYSE: JNJ). 858
McKesson Corporation ( NYSE: MCK) - McKesson Appoints Tracy Faber to Top HR Role -- 26/4/2019. 343
Merck & Co (NYSE:MRK). 3395
Pfizer Inc (NYSE:PFE). 4150
Regeneron Pharmaceuticals Inc (NASDAQ: REGN). 2416
Sanofi (NYSE:SNY). 5499
Teva (NYSE:TEVA). 4727
The Industry. 948

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters